Nov. 27, 2023— Gary Chandler was in good company when he visited Ascension Via Christi St. Francis in Wichita, Kansas, because he was feeling unwell. One-quarter of patients at the health system’s three hospitals in the Wichita area are on Medicaid or are uninsured, like Chandler was when he came in. But his diagnosis was much more uncommon – aplastic anemia, a rare blood … [Read more...]
For Patients, Symptoms of Drugmaker 340B Restrictions Include Shortness of Breath, Hospitalization
Dec. 23, 2022— The examples of worsened health outcomes for patients from drug company restrictions on 340B pricing to safety-net hospitals continue to mount. At Riverside Regional Medical Center in Virginia, one discharged patient with diabetes was readmitted to the hospital within days due to delayed access to an insulin medication for which drug companies had restricted … [Read more...]
30 Years of Care: A Happy, Healthy Anniversary for 340B!
Nov. 4, 2022— Today marks the 30th anniversary of the enactment of the 340B drug pricing program. With his signature on Nov. 4, 1992, President George H.W. Bush completed a bipartisan effort in Congress to protect the health care safety net and boost care for people living with low incomes. The new program was unusual in that it did not ask the American taxpayers to provide … [Read more...]
Faces of 340B: Patients Are Skipping Medications Because of Drug Company Restrictions
Sept. 23, 2022 – Southwest Mississippi Regional Medical Center (SMRMC) had big plans for how it could reach more patients in need in the communities that it serves. But that all changed when drug companies started restricting access to 340B drug pricing program discounts to SMRMC and other safety-net hospitals. “We had plans of extending our services to expand mental health … [Read more...]
340B Makes Major Contributions to Cancer Care
Sept. 13, 2022– President Biden’s call for a “moonshot” campaign to cut the death rate from cancer by at least 50% over the next 25 years focuses renewed attention on ensuring access to affordable cancer care for patients living with low incomes and those who live in often-underserved rural communities across the country. The 340B drug pricing program plays a vital role in … [Read more...]
Faces of 340B: Community Pharmacy Partnerships Aid in the Cancer Care Cause
April 22, 2022 – A bell rings and a round of applause is heard. A patient is marking the end of their cancer treatments at St. Anthony Regional Hospital in Carroll, Iowa. The patient knows the chemotherapy and radiation treatments they received from the St. Anthony Regional Cancer Center enabled them to reach this special day. What they may not realize is that the hospital’s … [Read more...]
Recognizing Patients on 340B’s Anniversary
Nov. 4, 2021 – Jennifer Gallagher was aware of the 340B drug pricing program as the lead pharmacy technician at Parkview Medical Center in Pueblo, Colo. But she says it was not until she had her own medical challenges that she came to understand what the program means to patients. Today she views 340B as playing a pivotal role in her ability to stay healthy and continue working … [Read more...]